Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · IEX Real-Time Price · USD
5.01
-0.04 (-0.79%)
At close: Apr 19, 2024, 4:00 PM
5.11
+0.10 (2.00%)
After-hours: Apr 19, 2024, 7:30 PM EDT
Capricor Therapeutics Market Cap
Capricor Therapeutics has a market cap or net worth of $157.83 million as of April 19, 2024. Its market cap has increased by 47.37% in one year.
Market Cap
157.83M
Enterprise Value
120.58M
1-Year Change
47.37%
Ranking
Category
Stock Price
$5.01
Market Cap Chart
Since May 14, 2007, Capricor Therapeutics's market cap has increased from $2.00M to $157.83M, an increase of 7,791.50%. That is a compound annual growth rate of 29.41%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 18, 2024 | 158.60M | -9.01% |
Apr 17, 2024 | 174.30M | -6.39% |
Apr 16, 2024 | 186.20M | 1.20% |
Apr 15, 2024 | 184.00M | -6.22% |
Apr 12, 2024 | 196.20M | 0.31% |
Apr 11, 2024 | 195.60M | -1.11% |
Apr 10, 2024 | 197.80M | -4.54% |
Apr 9, 2024 | 207.20M | 0.29% |
Apr 8, 2024 | 206.60M | -2.09% |
Apr 5, 2024 | 211.00M | 0.29% |
Apr 4, 2024 | 210.40M | -1.45% |
Apr 3, 2024 | 213.50M | -1.29% |
Apr 2, 2024 | 216.30M | -2.92% |
Apr 1, 2024 | 222.80M | 4.50% |
Mar 28, 2024 | 213.20M | 0.28% |
Mar 27, 2024 | 212.60M | 7.32% |
Mar 26, 2024 | 198.10M | -4.85% |
Mar 25, 2024 | 208.20M | 3.94% |
Mar 22, 2024 | 200.30M | -7.27% |
Mar 21, 2024 | 216.00M | 0.42% |
Mar 20, 2024 | 215.10M | 0.89% |
Mar 19, 2024 | 213.20M | 0.42% |
Mar 18, 2024 | 212.30M | 5.83% |
Mar 15, 2024 | 200.60M | 3.56% |
Mar 14, 2024 | 193.70M | 3.86% |
View and export this data all the way back to 2007.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
ProQR Therapeutics | 160.83M |
Harvard Bioscience | 160.58M |
Adicet Bio | 160.23M |
P3 Health Partners | 159.72M |
Cybin | 158.99M |
Inogen | 157.46M |
Greenwich LifeSciences | 155.44M |
Achieve Life Sciences | 154.48M |